Farkas S - Search Results

1

Clinical management of patients receiving cell-based immunoregulatory therapy.

Hutchinson JA, Ahrens N, Riquelme P, Walter L, Gruber M, Böger CA, Farkas S, Scherer MN, Broichhausen C, Bein T, Schlitt HJ, Fändrich F, Banas B, Geissler EK. Hutchinson JA, et al. Among authors: farkas s. Transfusion. 2014 Sep;54(9):2336-43. doi: 10.1111/trf.12641. Epub 2014 Apr 4. Transfusion. 2014. PMID: 24697195 Review.

2

Study protocol: a pilot study to determine the safety and efficacy of induction-therapy, de novo MPA and delayed mTOR-inhibition in liver transplant recipients with impaired renal function. PATRON-study.

Schnitzbauer AA, Scherer MN, Rochon J, Sothmann J, Farkas SA, Loss M, Geissler EK, Obed A, Schlitt HJ. Schnitzbauer AA, et al. BMC Nephrol. 2010 Sep 14;11:24. doi: 10.1186/1471-2369-11-24. BMC Nephrol. 2010. PMID: 20840760 Free PMC article. Clinical Trial.

3

Improved outcome after 'bottom-up' immunosuppression in liver transplant recipients with preoperative renal impairment.

Schnitzbauer AA, Doenecke A, Sothmann JL, Loss M, Farkas SA, Hartl J, Tsui TY, Baier L, Kirchner G, Obed A, Bein T, Geissler EK, Scherer MN, Schlitt HJ. Schnitzbauer AA, et al. Eur Surg Res. 2010;45(3-4):356-67. doi: 10.1159/000321702. Epub 2010 Nov 22. Eur Surg Res. 2010. PMID: 21088426

4

Distribution of intrahepatic T, NK and CD3(+)CD56(+)NKT cells alters after liver transplantation: Shift from innate to adaptive immunity?

Werner JM, Lang C, Scherer MN, Farkas SA, Geissler EK, Schlitt HJ, Hornung M. Werner JM, et al. Transpl Immunol. 2011 Jul;25(1):27-33. doi: 10.1016/j.trim.2011.05.006. Epub 2011 May 23. Transpl Immunol. 2011. PMID: 21635950 Clinical Trial.

5

[Operative therapy of hepatocellular carcinoma].

Farkas SA, Schlitt HJ. Farkas SA, et al. Radiologe. 2014 Jul;54(7):673-8. doi: 10.1007/s00117-014-2653-3. Radiologe. 2014. PMID: 25047523 Review. German.

6

Treatment-emergent adverse events after infusion of adherent stem cells: the MiSOT-I score for solid organ transplantation.

Dillmann J, Popp FC, Fillenberg B, Zeman F, Eggenhofer E, Farkas S, Scherer MN, Koller M, Geissler EK, Deans R, Ladenheim D, Loss M, Schlitt HJ, Dahlke MH. Dillmann J, et al. Among authors: farkas s. Trials. 2012 Nov 15;13:211. doi: 10.1186/1745-6215-13-211. Trials. 2012. PMID: 23151227 Free PMC article.

7

RANTES/CCL5 polymorphisms as a risk factor for recurrent acute rejection.

Krüger B, Böger CA, Obed A, Farkas S, Hoffmann U, Banas B, Fischereder M, Krämer BK. Krüger B, et al. Among authors: farkas s. Clin Transplant. 2007 May-Jun;21(3):385-90. doi: 10.1111/j.1399-0012.2006.00654.x. Clin Transplant. 2007. PMID: 17488389

8

No effect of C-reactive protein (CRP) haplotypes on CRP levels and post-transplant morbidity and mortality in renal transplantation.

Krüger B, Böger CA, Schröppel B, Farkas S, Schnitzbauer AA, Hoffmann U, Obed A, Murphy BT, Banas B, Krämer BK. Krüger B, et al. Among authors: farkas s. Transpl Int. 2008 May;21(5):452-8. doi: 10.1111/j.1432-2277.2007.00626.x. Epub 2008 Feb 4. Transpl Int. 2008. PMID: 18266777 Free article.

9

[Surgical technique for laparoscopic kidney donation].

Hackl C, Böger C, Schlitt HJ, Farkas S. Hackl C, et al. Among authors: farkas s. Zentralbl Chir. 2014 Oct;139(5):483-5. doi: 10.1055/s-0034-1383093. Epub 2014 Oct 14. Zentralbl Chir. 2014. PMID: 25313885 German.

10

The Authors' Reply.

Proneth A, Geissler EK, Schlitt HJ, Farkas SA. Proneth A, et al. Transplantation. 2018 Dec;102(12):e495. doi: 10.1097/TP.0000000000002439. Transplantation. 2018. PMID: 30461729 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

304 results

Search Page